About this webinar recording

Pharmaceutical and Life Science companies have caught the omnichannel bug. Around the world, they are quickly forming teams and investing millions.

Often, these initiatives are led by highly competent staff who have years of pharma experience, but they're suddenly being asked to develop and execute on content strategies and platforms vastly more complex than anything the company has done before.

And this is all to be executed whilst maintaining quality, compliance, and staff morale — a tall order!

This recording drawsupon case studies from the likes of Eli Lilly, Roche, and 3M Lifesciences to clearly define why and how of proven strategies and tactics that can help a pharma company move towards omnichannel.

We looked at how to successfully implement methods like component content (aka: 'atomic', 'modular', 'structured', 'reusable', “like Lego”…), omnichannel data and analytics integration, and tagging and categorising for personalisation and regional compliance at scale.

Outcomes and key takeaways

You'll learn:

• How pharma brands can begin their journey towards omnichannel
• How to engage inter-team stakeholder buy-in for your omnichannel strategy
• How different areas within the pharma enterprise can benefit from shared methodologies and tech — even if they involve very different audiences and processes
• What you should be looking for from your platforms when going omnichannel. How can you tell whether your tech stack is up to the job?